# CHINA SXT PHARMACEUTICALS INC CL A

CHINA SXT PHARMACEUTICALS INC CL A is a security (CUSIP G2161P165) tracked across SEC portfolio filings. 4 institutional managers reported $131K on Form 13F as of 2026-06-30.

## Summary

- Issuer: CHINA SXT PHARMACEUTICALS INC
- Class: CL A
- CUSIP: G2161P165
- 13F holders: 4
- 13F value: $131K
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [SABBY MANAGEMENT, LLC](https://search.stillhousedata.com/firm/162659) | Spicewood, TX | $131K | 78,170 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $4 | 2 |
| UBS Group AG | Zurich, V8 | $2 | 1 |
| Royal Bank of Canada | TORONTO, A6 | — | 13 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/G2161P165.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.